Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
Journal of Thoracic Disease|March 13, 2023
Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)Jun Yin, Siyun Lin, Yong Fang, et al.
BMC Cancer|February 19, 2025
A preoperative pathological staging prediction model for esophageal cancer based on CT radiomicsHaojun Li, Shuoming Liang, Mengxuan Cui, et al.
JAMA Network Open|January 6, 2026
Long-Term Survival Outcomes of NCRT With Surgery vs Surgery With Adjuvant Therapy for ESCC: A Single-Center Prospective Phase 3 Randomized Clinical TrialWenwu He, Zhiyu Li, Qin Xie, et al.
Journal of Thoracic Disease|October 29, 2025
Perineural invasion as a prognostic factor and the efficacy of upfront surgery for low-risk cT2/T3N0M0 esophageal squamous cell carcinoma patientsJicheng Xiong, Simiao Lu, Shuoming Liang, et al.
Frontiers in Oncology|July 1, 2025
Comparison of recurrence patterns between patients with thoracic esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and postoperative adjuvant chemoradiotherapyKunhan Ni, Yixuan Huang, Simiao Lu, et al.
BMJ Open|October 22, 2025
Real-world efficacy of PD-1 inhibitors in treating oesophageal squamous cell carcinoma (ESCAPE): protocol of a multicentre, real-world, observational, cohort studyChenghao Wang, Qin Xie, Yan Miao, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 21, 2018
Lymph node metastasis in thymic malignancies: A Chinese multicenter prospective observational studyWentao Fang, Yun Wang, Liewen Pang, et al.
Journal of Thoracic Disease|June 18, 2025
Impact of perineural invasion in thoracic esophageal squamous cell carcinoma-a retrospective study with long-term follow-up outcomesJicheng Xiong, Simiao Lu, Shuoming Liang, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 1, 2022
Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in ChinaYang Yang, Lijie Tan, Jian Hu, et al.
Thoracic Cancer|October 3, 2018
Adjuvant radiotherapy, chemotherapy or surgery alone for high-risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trialXufeng Guo, Wentao Fang, Zhigang Li, et al.
Pageof 17